aminoimidazole carboxamide has been researched along with alpha-synuclein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardah, MT; Dulovic, M; El-Agnaf, OM; Harhaji-Trajkovic, L; Jovanovic, M; Kostic, V; Kravic-Stevovic, T; Markovic, I; Paunovic, V; Stefanis, L; Trajkovic, V; Xilouri, M | 1 |
1 other study(ies) available for aminoimidazole carboxamide and alpha-synuclein
| Article | Year |
|---|---|
The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.
Topics: alpha-Synuclein; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cell Death; Cell Differentiation; Cells, Cultured; Cerebral Cortex; Culture Media, Conditioned; DNA Fragmentation; Embryo, Mammalian; Humans; Hypoglycemic Agents; Metformin; Neuroblastoma; Neurons; Protein Serine-Threonine Kinases; Rats; Ribonucleotides; RNA, Small Interfering; Tretinoin | 2014 |